Aequus Pharmaceuticals Stock Buy Hold or Sell Recommendation
| AQSZF Stock | USD 0.01 0.0005 7.04% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Aequus Pharmaceuticals is 'Strong Sell'. Macroaxis provides Aequus Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AQSZF positions.
Check out Aequus Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Aequus and provide practical buy, sell, or hold advice based on investors' constraints. Aequus Pharmaceuticals. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Aequus |
Execute Aequus Pharmaceuticals Buy or Sell Advice
The Aequus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aequus Pharmaceuticals. Macroaxis does not own or have any residual interests in Aequus Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aequus Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Aequus Pharmaceuticals Trading Alerts and Improvement Suggestions
| Aequus Pharmaceuticals generated a negative expected return over the last 90 days | |
| Aequus Pharmaceuticals has high historical volatility and very poor performance | |
| Aequus Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aequus Pharmaceuticals has accumulated 26.09 K in total debt with debt to equity ratio (D/E) of 1.39, which is about average as compared to similar companies. Aequus Pharmaceuticals has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Aequus Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Aequus Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aequus Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aequus to invest in growth at high rates of return. When we think about Aequus Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 2.71 M. Net Loss for the year was (1.81 M) with profit before overhead, payroll, taxes, and interest of 2.69 M. | |
| Aequus Pharmaceuticals has accumulated about 1.39 M in cash with (1.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of Aequus Pharmaceuticals shares are held by company insiders |
Aequus Pharmaceuticals Returns Distribution Density
The distribution of Aequus Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Aequus Pharmaceuticals' future price movements. The chart of the probability distribution of Aequus Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Aequus Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aequus Pharmaceuticals returns is essential to provide solid investment advice for Aequus Pharmaceuticals.
| Mean Return | -0.92 | Value At Risk | -10.64 | Potential Upside | 2.22 | Standard Deviation | 6.87 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aequus Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aequus Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aequus Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aequus Pharmaceuticals' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aequus otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.12 | |
β | Beta against Dow Jones | 1.52 | |
σ | Overall volatility | 6.92 | |
Ir | Information ratio | -0.15 |
Aequus Pharmaceuticals Volatility Alert
Aequus Pharmaceuticals is displaying above-average volatility over the selected time horizon. Aequus Pharmaceuticals is a penny stock. Even though Aequus Pharmaceuticals may be a good instrument to invest, many penny otc stocks are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Aequus Pharmaceuticals or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Aequus instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Aequus Pharmaceuticals Fundamentals Vs Peers
Comparing Aequus Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aequus Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Aequus Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aequus Pharmaceuticals or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aequus Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aequus Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aequus Pharmaceuticals to competition |
| Fundamentals | Aequus Pharmaceuticals | Peer Average |
| Return On Equity | -2.92 | -0.31 |
| Return On Asset | -0.42 | -0.14 |
| Profit Margin | (1.36) % | (1.27) % |
| Operating Margin | (1.31) % | (5.51) % |
| Current Valuation | 3.03 M | 16.62 B |
| Shares Outstanding | 132.63 M | 571.82 M |
| Shares Owned By Insiders | 14.96 % | 10.09 % |
| Price To Earning | (1.79) X | 28.72 X |
| Price To Book | 32.78 X | 9.51 X |
| Price To Sales | 1.44 X | 11.42 X |
| Revenue | 2.71 M | 9.43 B |
| Gross Profit | 2.69 M | 27.38 B |
| EBITDA | (1.23 M) | 3.9 B |
| Net Income | (1.81 M) | 570.98 M |
| Cash And Equivalents | 1.39 M | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 26.09 K | 5.32 B |
| Debt To Equity | 1.39 % | 48.70 % |
| Current Ratio | 0.78 X | 2.16 X |
| Book Value Per Share | (0) X | 1.93 K |
| Cash Flow From Operations | (1.17 M) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 14 | 18.84 K |
| Beta | 0.44 | -0.15 |
| Market Capitalization | 4.12 M | 19.03 B |
| Total Asset | 4.35 M | 29.47 B |
| Retained Earnings | (5.72 M) | 9.33 B |
| Working Capital | (246 K) | 1.48 B |
| Current Asset | 458 K | 9.34 B |
| Current Liabilities | 704 K | 7.9 B |
| Z Score | 93.4 | 8.72 |
| Net Asset | 4.35 M |
Aequus Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aequus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.42 | |||
| Daily Balance Of Power | (0.16) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 0.0061 | |||
| Day Typical Price | 0.0063 | |||
| Market Facilitation Index | 0.0032 | |||
| Price Action Indicator | 3.0E-4 | |||
| Period Momentum Indicator | (0.0005) | |||
| Relative Strength Index | 90.17 |
About Aequus Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Aequus Pharmaceuticals? Buying financial instruments such as Aequus OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aequus Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run High Yield ETFs Thematic Idea Now
High Yield ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Yield ETFs theme has 105 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Yield ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Aequus OTC Stock
Aequus Pharmaceuticals financial ratios help investors to determine whether Aequus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aequus with respect to the benefits of owning Aequus Pharmaceuticals security.